Your Biopharmaceutical Development and Manufacturing Partner

Peter H. Khoury, Ph.D., MBA Appointed President and Chief Executive Officer of Nanotherapeutics

ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a biologics focused contract development and manufacturing organization (CDMO), today announced that Peter H. Khoury, Ph.D., MBA, formerly Senior Vice President and Chief Commercial Officer, has been appointed President and Chief Executive Officer of the Company.

Read the full article at Business Wire

Copyright 2017 NANOTHERAPEUTICS, INC.  All rights reserved.